Combined inherited protein S and heparin co-factor II deficiency in a patient with upper limb thrombosis : a family studySIMIONI, P; ZANARDI, S; PRANDONI, P et al.Thrombosis research. 1992, Vol 67, Num 1, pp 23-30, issn 0049-3848Article

The N-terminal acidic domain of heparin cofactor II mediates the inhibition of α-thrombin in the presence of glycosaminoglycansVAN DEERLIN, V. M. D; TOLLEFSEN, D. M.The Journal of biological chemistry (Print). 1991, Vol 266, Num 30, pp 20223-20231, issn 0021-9258Article

Heparin cofactor II in adults and infants with thrombosis and DICCHUANSUMRIT, A; MANCO-JOHNSON, M. J; HATHAWAY, W. E et al.American journal of hematology. 1989, Vol 31, Num 2, pp 109-113, issn 0361-8609Article

Synthesis of a dermatan sulphate-like hexasacharide with a non-glycosamino glycan structureBASTEN, J. E. M; VAN BOECKEL, C. A. A; JAURAND, G et al.Bioorganic & medicinal chemistry letters (Print). 1994, Vol 4, Num 7, pp 893-898, issn 0960-894XArticle

Antithrombin III- and heparin cofactor II-mediated anticoagulant and antiprotease actions of heparin and its synthetic analoguesJESKE, W; JAWED FAREED.Seminars in thrombosis and hemostasis. 1993, Vol 19, pp 241-247, issn 0094-6176, SUP1Article

Use of purified dermatan sulfate for heparin cofactor II (HC II) assayRUZZENENTE, O; GHIDINI, R; POLI, G et al.Thrombosis research. 1992, Vol 65, Num 2, pp 281-287, issn 0049-3848Article

Heparin cofactor II deficiency in renal allograft recipients : no correlation with the development of thrombosisTOULON, P; MOULONGUET-DOLERIS, L; COSTA, J. M et al.Thrombosis and haemostasis. 1991, Vol 65, Num 1, pp 20-24, issn 0340-6245Article

Evidence for a reduced heparin cofactor II biological activity in diabetesCARIELLO, A; QUATRARO, A; DELLO RUSSO, P et al.Haemostasis. 1990, Vol 20, Num 6, pp 357-361, issn 0301-0147, 5 p.Article

Heparin cofactor II, antithrombin and protein C in plasma from term and preterm infantsANDERSSON, T. R; BANGSTAD, H; LARSEN, M. L et al.Acta paediatrica scandinavica. 1988, Vol 77, Num 4, pp 485-488, issn 0001-656XArticle

Plasma and urinary heparin cofactor II levels in patients with nephrotic syndromeGRAU, E; OLIVER, A; FELEZ, J et al.Thrombosis and haemostasis. 1988, Vol 60, Num 2, pp 137-140, issn 0340-6245Article

Plama heparin cofactor II, protein C and antithrombin in elective surgeryANDERSSON, T. R; BERNER, N. S; LARSEN, M. L et al.Acta chirurgica scandinavica. 1987, Vol 153, Num 4, pp 291-296, issn 0001-5482Article

Thrombin inhibitory activity of heparin cofactor II depends on the molecular weight and sulfate amount of dextran sulfateYAMAGISHI, R; NIWA, M; SAKURAGAWA, N et al.Thrombosis research. 1986, Vol 44, Num 3, pp 347-354, issn 0049-3848Article

Antithrombotic and anticomplementary properties of a very low molecular mass dermatan sulfateFABIANA ALBERTO, Maria; GIAQUINTA ROMERO, Diego; LAZZARI, Maria et al.Thrombosis research. 2008, Vol 122, Num 1, pp 109-116, issn 0049-3848, 8 p.Article

The medicinal plant Porana volubilis contains polysaccharides with anticoagulant activity mediated by heparin cofactor IIYOON, Seon-Joo; PEREIRA, Mariana S; PAVAO, Mauro S. G et al.Thrombosis research. 2002, Vol 106, Num 1, pp 51-58, issn 0049-3848Article

Insight into the mechanism of action of heparin cofactor IITOLLEFSEN, D. M.Thrombosis and haemostasis. 1995, Vol 74, Num 5, pp 1209-1214, issn 0340-6245Article

Structural features of heparin and their effect on heparin cofactor II mediated inhibition of thrombinKIM, Y. S; LINHARDT, R. J.Thrombosis research. 1989, Vol 53, Num 1, pp 55-71, issn 0049-3848Article

Characterization of a novel dermatan sulfate with high antithrombin activity from ray skin (Raja radula)MOHAMED BEN MANSOUR; DHAHRI, Manel; BERTHOLON, Isabelle et al.Thrombosis research. 2009, Vol 123, Num 6, pp 887-894, issn 0049-3848, 8 p.Article

A small fraction of dermatan sulfate with significantly increased anticoagulant activity was selected by interaction with the first complement proteinCALABRESE, Graciela C; ALBERTO, Maria F; TUBIO, Rosario et al.Thrombosis research. 2004, Vol 113, Num 3-4, pp 243-250, issn 0049-3848, 8 p.Article

Heparin cofactor II, antithrombin-β and their complexes with thrombin in human tissuesKAMP, Paul-Bertram; STRATHMANN, Annemarie; RAGG, Hermann et al.Thrombosis research. 2001, Vol 101, Num 6, pp 483-491, issn 0049-3848Article

Regulation of thrombosis and hemostasis by antithrombinSAKURAGAWA, N.Seminars in thrombosis and hemostasis. 1997, Vol 23, Num 6, pp 557-562, issn 0094-6176Article

Contribution à l'étude de l'activité anticoagulante du dermatane sulfate: Synthèse de fragments oligosaccharidiques = Study of the anticoagulant action of dermatane sultate: Synthesis of tetra and hexa oligosaccharidic fragmentsBourhis, Pascal; Sinäy, P.1995, 175 p.Thesis

Heparin cofactor II in diabetic patientsDUBOSCQ, C; QUINTANA, I; BARROS, J et al.Blood coagulation & fibrinolysis. 1994, Vol 5, Num 2, pp 201-204, issn 0957-5235Article

Interaction of heparin cofactor II with biglycan and decorinWHINNA, H. C; CHOI, H. U; ROSENBERG, L. C et al.The Journal of biological chemistry (Print). 1993, Vol 268, Num 6, pp 3920-3924, issn 0021-9258Article

Increased heparin cofactor II levels in women taking oral contraceptivesTOULON, P; BARDIN, J. M; BLUMENFELD, N et al.Thrombosis and haemostasis. 1990, Vol 64, Num 3, pp 365-368, issn 0340-6245, 4 p.Article

Non-enzymatic glycations reduces heparin cofactor II anti-thrombin activityCERIELLO, A; MARCHI, E; BARBANTI, M et al.Diabetologia (Berlin). 1990, Vol 33, Num 4, pp 205-207, issn 0012-186X, 3 p.Article